How to buy Johnson-and-Johnson stock | $164.82

Johnson & Johnson (JNJ) is a leading drug manufacturers-general business based in the US. It opened the day at $164.51 after a previous close of $163.93. During the day the price has varied from a low of $164.21 to a high of $165.77. The latest price was $164.82 (25 minute delay). Johnson-and-Johnson is listed on the NYSE and employs 136,000 staff. All prices are listed in US Dollars.

Johnson-and-Johnson stock price (NYSE: JNJ)

Use our graph to track the performance of JNJ stocks over time.

Johnson-and-Johnson shares at a glance

• Live prices
• Key figures

Information last updated 2021-09-23.

Open	$164.51
High	$165.77
Low	$164.21
Close	$164.82
Previous close	$163.93
Change	$0.89
Change %	0.5429%
Volume	4,525,097

Information last updated 2021-09-17.

52-week range	$130.31 - $178.93
50-day moving average	$173.17
200-day moving average	$167.11
Wall St. target price	$188.88
PE ratio	24.6678
Dividend yield	$4.09 (2.48%)
Earnings per share (TTM)	$6.65

Buy Johnson-and-Johnson shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Johnson-and-Johnson stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Johnson-and-Johnson price performance over time

Historical closes compared with the close of $164.82 from 2021-09-23

1 week (2021-09-16)	-0.24%
1 month (2021-08-24)	-6.03%
3 months (2021-06-24)	0.89%
6 months (2021-03-24)	1.80%

1 year (2020-09-24)	13.93%
2 years (2019-09-24)	25.29%
3 years (2018-09-24)	17.33%
5 years (2016-09-23)	38.73%

Is Johnson-and-Johnson under- or over-valued?

Valuing Johnson-and-Johnson stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Johnson-and-Johnson's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Johnson-and-Johnson's P/E ratio

Johnson-and-Johnson's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 25x. In other words, Johnson-and-Johnson shares trade at around 25x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Johnson-and-Johnson's PEG ratio

Johnson-and-Johnson's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.6794. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Johnson-and-Johnson's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Johnson-and-Johnson's EBITDA

Johnson-and-Johnson's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $30.7 billion.

The EBITDA is a measure of a Johnson-and-Johnson's overall financial performance and is widely used to measure a its profitability.

Johnson-and-Johnson financials

Revenue TTM	$89.2 billion
Operating margin TTM	25.98%
Gross profit TTM	$54.3 billion
Return on assets TTM	8.65%
Return on equity TTM	26.81%
Profit margin	19.92%
Book value	$26.44
Market capitalisation	$432 billion

TTM: trailing 12 months

Shorting Johnson-and-Johnson shares

There are currently 16.4 million Johnson-and-Johnson shares held short by investors – that's known as Johnson-and-Johnson's "short interest". This figure is 4.8% down from 17.2 million last month.

There are a few different ways that this level of interest in shorting Johnson-and-Johnson shares can be evaluated.

Johnson-and-Johnson's "short interest ratio" (SIR)

Johnson-and-Johnson's "short interest ratio" (SIR) is the quantity of Johnson-and-Johnson shares currently shorted divided by the average quantity of Johnson-and-Johnson shares traded daily (recently around 5.2 million). Johnson-and-Johnson's SIR currently stands at 3.14. In other words for every 100,000 Johnson-and-Johnson shares traded daily on the market, roughly 3140 shares are currently held short.

However Johnson-and-Johnson's short interest can also be evaluated against the total number of Johnson-and-Johnson shares, or, against the total number of tradable Johnson-and-Johnson shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Johnson-and-Johnson's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Johnson-and-Johnson shares in existence, roughly 10 shares are currently held short) or 0.0062% of the tradable shares (for every 100,000 tradable Johnson-and-Johnson shares, roughly 6 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Johnson-and-Johnson.

Find out more about how you can short Johnson-and-Johnson stock.

Johnson-and-Johnson's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Johnson-and-Johnson.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Johnson-and-Johnson's total ESG risk score

Total ESG risk: 35.8

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Johnson-and-Johnson's overall score of 35.8 (as at 12/31/2018) is pretty weak – landing it in it in the 72nd percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Johnson-and-Johnson is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Johnson-and-Johnson's environmental score

Environmental score: 3.79/100

Johnson-and-Johnson's environmental score of 3.79 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Johnson-and-Johnson is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Johnson-and-Johnson's social score

Social score: 25.14/100

Johnson-and-Johnson's social score of 25.14 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Johnson-and-Johnson is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Johnson-and-Johnson's governance score

Governance score: 14.87/100

Johnson-and-Johnson's governance score puts it squarely in the 7th percentile of companies rated in the same sector. That could suggest that Johnson-and-Johnson is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Johnson-and-Johnson's controversy score

Controversy score: 4/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Johnson-and-Johnson scored a 4 out of 5 for controversy – the second-lowest score possible, reflecting that Johnson-and-Johnson has a damaged public profile.

Environmental, social, and governance (ESG) summary

Johnson & Johnson was last rated for ESG on: 2019-01-01.

Total ESG score	35.8
Total ESG percentile	72.38
Environmental score	3.79
Environmental score percentile	7
Social score	25.14
Social score percentile	7
Governance score	14.87
Governance score percentile	7
Level of controversy	4

Johnson-and-Johnson share dividends

Dividend payout ratio: 45.35% of net profits

Recently Johnson-and-Johnson has paid out, on average, around 45.35% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.57% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Johnson-and-Johnson shareholders could enjoy a 2.57% return on their shares, in the form of dividend payments. In Johnson-and-Johnson's case, that would currently equate to about $4.09 per share.

While Johnson-and-Johnson's payout ratio might seem fairly standard, it's worth remembering that Johnson-and-Johnson may be investing much of the rest of its net profits in future growth.

Johnson-and-Johnson's most recent dividend payout was on 6 September 2021. The latest dividend was paid out to all shareholders who bought their shares by 22 August 2021 (the "ex-dividend date").

Have Johnson-and-Johnson's shares ever split?

Johnson-and-Johnson's shares were split on a 2:1 basis on 12 June 2001. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Johnson-and-Johnson shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Johnson-and-Johnson shares which in turn could have impacted Johnson-and-Johnson's share price.

Johnson-and-Johnson share price volatility

Over the last 12 months, Johnson-and-Johnson's shares have ranged in value from as little as $130.313 up to $178.93. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Johnson-and-Johnson's is 0.7047. This would suggest that Johnson-and-Johnson's shares are less volatile than average (for this exchange).

Johnson-and-Johnson overview

Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o. b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand.

Frequently asked questions

What percentage of Johnson-and-Johnson is owned by insiders or institutions?
Currently 0.081% of Johnson-and-Johnson shares are held by insiders and 69.406% by institutions. How many people work for Johnson-and-Johnson?
Latest data suggests 136,000 work at Johnson-and-Johnson. When does the fiscal year end for Johnson-and-Johnson?
Johnson-and-Johnson's fiscal year ends in December. Where is Johnson-and-Johnson based?
Johnson-and-Johnson's address is: One Johnson & Johnson Plaza, New Brunswick, NJ, United States, 08933 What is Johnson-and-Johnson's ISIN number?
Johnson-and-Johnson's international securities identification number is: US4781601046 What is Johnson-and-Johnson's CUSIP number?
Johnson-and-Johnson's Committee on Uniform Securities Identification Procedures number is: 478160104